Boston Scientific(BSX)

Search documents
Buy 5 Surging Old Economy Stocks to Tap Market Rally
ZACKS· 2024-08-09 14:52
U.S. stock markets have rebounded from last week’s devastations. The Wall Street rally, which started in January 2023, saw a significant change in July 2024. The rally was predominantly driven by the technology sector. An unprecedented adoption of generative artificial intelligence (AI) technology globally was the prime factor.Companies that have extensive applications of AI in their final products have become multi-baggers in the past 18 months. Stock prices of some of these companies have skyrocketed 200- ...
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
ZACKS· 2024-08-09 14:30
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Let's take a look at what these Wall Street heavyweights have to say about Boston Scientific (BSX) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Boston Scientific currently has an average brokerage re ...
3 Reasons Why Growth Investors Shouldn't Overlook Boston Scientific (BSX)
ZACKS· 2024-08-06 17:46
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, it's pretty easy to find cutting-edge growth stocks with the he ...
Boston Scientific(BSX) - 2024 Q2 - Quarterly Report
2024-08-01 20:16
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 1-11083 BOSTON SCIENTIFIC CORPORATION (Exact name of registrant as specified in its charter) Delaware 04-2695240 (State or other jurisdiction of incorporation or or ...
Boston Scientific (BSX) Rides on Global Growth, Buyouts
ZACKS· 2024-07-31 17:30
Boston Scientific Corporation (BSX) is gaining traction in the emerging markets. New regulatory approvals and accretive acquisitions bode well for long-term growth. The stock carries a Zacks Rank #2 (Buy) currently.Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States. In the last reported second quarter of 2024, despite geopolitical weaknesses, the emerging market registered sturdy growth, primarily banking on continued broad-based ...
3 Record-Breaking Stocks With More Upside Ahead
Investor Place· 2024-07-26 11:25
2024 has been a great year for U.S. indices, with the benchmark S&P 500 posting new all-time highs 38 times so far. The rally has been primarily driven by the tech sector, focusing on artificial intelligence (AI). Several record-breaking stocks have seen triple-digit returns.However, the markets appear to have taken a summer breather in July. This raises the question of whether it’s time to buy the dip under the theory that record-breaking stocks have more upside ahead.While AI stocks have been the leader i ...
Boston Scientific (BSX) Q2 Earnings Beat, Organic Sales Rise
ZACKS· 2024-07-24 17:50
Boston Scientific Corporation (BSX) posted adjusted earnings per share (EPS) of 62 cents for the second quarter of 2024, up 16.9% from the year-ago figure. The figure beat the Zacks Consensus Estimate by 6.9% and also exceeded the company’s adjusted earnings per share guidance range of 57-59 cents per share.The quarter’s adjustments included certain intangible asset impairment charges, amortization expenses, acquisition/divestitures-related net charges, and restructuring and restructuring-related charges, a ...
Boston Scientific Profit and Sales Are Boosted by Cardiovascular Device Demand
Investopedia· 2024-07-24 16:41
Key TakeawaysBoston Scientific's second-quarter earnings and revenue got a boost from high demand for its heart devices.Sales of cardiovascular products made up more than half of the company's revenue in the period.Boston Scientific raised its full-year adjusted earnings per share (EPS) and revenue growth estimates. Boston Scientific (BSX) posted an increase in second-quarter earnings and sales on the back of growing demand for its heart devices. The medical device maker recorded adjusted earnings per share ...
Boston Scientific(BSX) - 2024 Q2 - Earnings Call Transcript
2024-07-24 14:57
Boston Scientific Corporation (NYSE:BSX) Q2 2024 Earnings Conference Call July 24, 2024 8:00 AM ET Company Participants Jon Monson - SVP, IR Michael F. Mahoney - Chairman and CEO Daniel J. Brennan - EVP and CFO Kenneth Stein - SVP, Global Chief Medical Officer Conference Call Participants Robert Marcus - J.P. Morgan Joanne Wuensch - Citigroup Inc. Lawrence Biegelsen - Wells Fargo Securities Frederick Wise - Stifel, Nicolaus & Company Vijay Kumar - Evercore ISI David Roman - Goldman Sachs Patrick Wood - Morg ...
Boston Scientific (BSX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2024-07-24 14:35
Boston Scientific (BSX) reported $4.12 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 14.5%. EPS of $0.62 for the same period compares to $0.53 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $4.02 billion, representing a surprise of +2.51%. The company delivered an EPS surprise of +6.90%, with the consensus EPS estimate being $0.58.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall ...